Researchers test mRNA technology for universal flu vaccine

Successful tests in animal models pave way for strategy for universal flu vaccine

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, according to a study. This could serve one day as a general preventative measure against future flu pandemics, the researchers from University of Pennsylvania, US, said.

New study on mice paves way for developing universal flu vaccine

Scientists have developed an mRNA lipid nanoparticle vaccine containing antigens from all twenty known subtypes of influenza A and B viruses, a strategy which may serve as the basis for universal flu vaccines, according to a study.

Universal flu vaccine may be available within two years, says scientist

Vaccine against all strains of virus hailed as major step in protecting against potentially devastating flu pandemic

Researchers test mRNA technology for universal flu vaccine

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially

Latest study in mice paves way for developing universal flu vaccine: Report

The approach by the scientists differed from previous attempts to craft a universal flu vaccine by including antigens specific to each subtype, rather than just a smaller set of antigens shared among subtypes, the study published in the journal Science said.

Latest study in mice paves way for developing universal flu vaccine

According to the study, even with increased global surveillance, it is difficult to predict which flu strain will cause the next flu pandemic